|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral Contraceptive use and fibrocystic breast disease with special reference |
| Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS |
| Journal of the National Cancer Institute. 1983 Jul;71(1):5-9. |
| The relationship between use of oral contraceptives (OCs) and fibrocystic breast disease was examined in a |
| hospital-based case-control study undertaken in New Haven, Connecticut, from 1977-79. Particular emphasis was |
| placed on the extent of epithelial atypia and other histopathologic characteristics found in the biopsy specimens |
| from the cases. Women who had ever used OCs were at a somewhat decreased risk for fibrocystic disease as a |
| whole. Cases with high atypia and controls had similar patterns of OC use, whereas cases with low and |
| intermediate atypia has less OC use than controls. Cases with intermidiate atypia reported the lowest OC use. |
| Subjects with biopsy specimens exhibiting gross cysts, microscopic cysts, or papillomatosis were about 50% less |
| likely to have used OCs than controls. (author's) (PubHealth.info Document ID: CONT5T 2071-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral Contraceptive use and fibrocystic breast disease with |
| special reference to its histopathology.", is(are) Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; |
| Goldenberg IS. The source of this article is "Journal of the National Cancer Institute. 1983 Jul;71(1):5-9.". This article |
| was published in 1983 in English language(s). (PubHealth.info® Document ID: CONT5T 2071-06. All rights reserved |
| with PubHealth.info) PIN: 22071 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |